Startups
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
Summary
26
Industry
Total funding Amount
$16M
Fundraising History
-
Seed$16M
Investors
-
Novo A/SSeed
-
Pureos BioventuresSeed